Invention Grant
- Patent Title: Pyrrolopyrazine kinase inhibitors
- Patent Title (中): 吡咯吡嗪激酶抑制剂
-
Application No.: US12378978Application Date: 2009-02-20
-
Publication No.: US07939531B2Publication Date: 2011-05-10
- Inventor: Joe Timothy Bamberg , Mark Bartlett , Daisy Joe DuBois , Todd Richard Elworthy , Robert Than Hendricks , Johannes Cornelius Hermann , Rama K. Kondru , Remy Lemoine , Yan Lou , Timothy D. Owens , Jaehyeon Park , David Bernard Smith , Michael Soth , Hanbiao Yang , Calvin Wesley Yee
- Applicant: Joe Timothy Bamberg , Mark Bartlett , Daisy Joe DuBois , Todd Richard Elworthy , Robert Than Hendricks , Johannes Cornelius Hermann , Rama K. Kondru , Remy Lemoine , Yan Lou , Timothy D. Owens , Jaehyeon Park , David Bernard Smith , Michael Soth , Hanbiao Yang , Calvin Wesley Yee
- Applicant Address: US CA Palo Alto
- Assignee: Roche Palo Alto
- Current Assignee: Roche Palo Alto
- Current Assignee Address: US CA Palo Alto
- Agent George W. Johnston; Dennis P. Tramaloni; Jennifer L. Kisko
- Main IPC: A61K31/495
- IPC: A61K31/495
Abstract:
The present invention relates to the use of novel pyrrolopyrazine derivatives of Formula I, wherein the variables Q and R are defined as described herein, which inhibit JAK and SYK and are useful for the treatment of auto-immune and inflammatory diseases.
Public/Granted literature
- US20090215750A1 Pyrrolopyrazine kinase inhibitors Public/Granted day:2009-08-27
Information query
